AMCPNexus_Brown_Apa_RP-Relugolix

Necessary Cookies

Necessary cookies make a website usable by enabling basic functions such as page navigation and access to secure areas of the website. These cookies cannot be switched off in Parexel’s systems. They are usually only set in response to actions made by you, which amount to a request for services, such as setting your privacy preferences, logging in or completing forms. You may be able to decline these cookies through your browser, but necessary parts of the website will then not work. These cookies do not store any personally identifiable information.

Cookie	Expiry	Domain	Company	Purpose
Cookie pxlCookieConsent	Expiry Session	Domain staging.tannwestlake.com	Company Parexel	Purpose Necessary
DescriptionStores your cookie consent session for our site. It contains no information other than whether you have opted in or out for each cookie level.
Cookie wordpress_test_cookie	Expiry Session	Domain staging.tannwestlake.com	Company Parexel	Purpose Necessary
DescriptionTests that the browser accepts cookies.

Standard
Larger
Extra Large

Standard Contrast
Low Contrast
High Contrast

Concomitant Apalutamide and Relugolix in Patients With High-Risk Localized Prostate Cancer: Testosterone Suppression 1-Year Update

Download Poster

Download Supplementary Material

Authors

Gordon Brown, Laurence Belkoff, Jason Hafron, Pankaj Aggarwal, Rushikesh Potdar, Amitabha Bhaumik, Jennifer Phillips, Tracy McGowan, Neal Shore

Poster presented at

AMCP NEXUS 2023; October 16-19, Orlando, Florida, USA.

All copyrights remain those of the copyright holder. This page will not be available after November 19, 2023.